Protagonist Therapeutics, Inc (PTGX) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US74366E1029
Protagonist Therapeutics, Inc financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 46.02 m USD |
| Operating income | -158.13 m USD |
| EBIT | -158.10 m USD |
| Net income | -130.15 m USD |
| Diluted EPS – continuing operations | -2.05 USD |
Full history since 2013, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Protagonist Therapeutics, Inc
Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.
More stocks
- FORMFACTOR INC (FORM)
- Oracle Corp Japan (4716.T)
- Pegatron Corp (4938.TW)
- Rexford Industrial Realty, Inc. (REXR)
- Zhaojin Mining Industry Co Ltd (1818.HK)
- Sembcorp Industries Ltd (U96.SI)
- Nedbank Group Ltd (NED.JO)
- Kingfisher PLC (KGF.L)
- LEVI STRAUSS & CO (LEVI)
- Melrose Industries PLC (MRO.L)
- WESTERN ALLIANCE BANCORPORATION (WAL)
- Zabka Group SA (ZAB.WA)
Not investment advice. All data without warranty, price as of 16.10.2026. Details in the risk notice.